Thrombelastogram in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery
|ClinicalTrials.gov Identifier: NCT00778492|
Recruitment Status : Unknown
Verified October 2008 by Sheba Medical Center.
Recruitment status was: Recruiting
First Posted : October 23, 2008
Last Update Posted : October 23, 2008
|Condition or disease|
Prospective observational study with blinded assessment of study endpoint variables. Collection of information concerning study endpoints will be performed by the investigator blinded to the results of preoperative testing of platelet function. The information will be collected from 60 patients undergoing cardiac surgery in the Department of Cardiac Surgery of Sheba Medical Center.
- Primary endpoint- resternotomy for bleeding after the surgery.
- Secondary endpoints- chest tube output during first 24 hours after the surgery; consumption of blood products during first 3 postoperative days.
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Official Title:||Thrombelastogram and Predicting Microvascular Bleeding in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery|
|Study Start Date :||May 2008|
|Estimated Primary Completion Date :||October 2008|
|Estimated Study Completion Date :||December 2008|
Patients with the history of ingestion of aspirin and/or ADP receptor antagonist (clopidogrel or ticlopidine) for at least 7 days prior the surgery. All patients undergoing cardiac surgery with the use of cardiopulmonary bypass on elective and urgent basis.
- Re-sternotomy d/t Bleeding [ Time Frame: Hospitalization Period ]
- Chest tube output during first 24 hours after the surgery [ Time Frame: 24 hours ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00778492
|Sheba Medical Center||Recruiting|
|Tel Hashomer, Israel, 52621|
|Contact: Sergey Preisman, MD 052-6667205 firstname.lastname@example.org|
|Principal Investigator: Sergey Preisman, MD|
|Principal Investigator:||Sergey Preisman, MD||Sheba Medical Center|
|Study Director:||Alexander Kogan, MD||Sheba Medical Center|